Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07025109 · ClinicalTrials.gov registry record · NA

Assessing Peer Support for Physical Activity in Women With HIV and Hypertension

A NA study of Hypertension and HIV, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07025109 is a NA study of Hypertension and HIV that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07025109, a NA study of Hypertension and HIV, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial will assess the acceptability and feasibility of a peer-supported behavioral physical activity intervention for women living with HIV and Hypertension.

Conditions Studied

Interventions

  • BEHAVIORAL Peer support
  • BEHAVIORAL Exercise Prescription
  • BEHAVIORAL Blood pressure self monitoring

Study Locations (1)

Alabama

  • Department of Family & Community Medicine; University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-02-06
Est. Completion 2026-07-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT07025109

The ClinicalTrials.gov registry entry for NCT07025109 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Peer support is the first listed.

NCT07025109 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT07025109 about?

NCT07025109 is a clinical study titled "Assessing Peer Support for Physical Activity in Women With HIV and Hypertension". This clinical trial will assess the acceptability and feasibility of a peer-supported behavioral physical activity intervention for women living with HIV and Hypertension.

What is the current status of trial NCT07025109?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-02-06. Estimated completion is 2026-07-31.

What conditions does trial NCT07025109 study?

This clinical trial studies the following conditions: Hypertension, HIV.

What interventions are being tested in trial NCT07025109?

The interventions under investigation include: Peer support (BEHAVIORAL), Exercise Prescription (BEHAVIORAL), Blood pressure self monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT07025109?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07025109 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.